SCINAI IMMUNOTHERAPEUTICS LTD.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -835.6% | -835.6% | -25.6% |
| FY2022 | 329.3% | 329.3% | -21.4% |
| FY2023 | 142.3% | 142.3% | -37.2% |
| FY2024 | 48.1% | 48.1% | 35.7% |
| FY2025 | -102.5% | -102.5% | -71.5% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -835.6% | -835.6% | -25.6% |
| FY2022 | 329.3% | 329.3% | -21.4% |
| FY2023 | 142.3% | 142.3% | -37.2% |
| FY2024 | 48.1% | 48.1% | 35.7% |
| FY2025 | -102.5% | -102.5% | -71.5% |